Pharmaceuticals
Pharmaceuticals is losing market weight. Gained weight for 3 consecutive months.
Most of this industry's losses came from a few companies.
Where did the weight change come from?
12-month contribution in universe percentage points · contributions add to the industry change
The three largest same-direction contributors explain 79% of gross losses. Opposing contributions can make an individual company’s change larger than the industry’s net change.
How has it moved through history?
Share of matched S&P 500 members
Jan 2018 – Nov 2018 · market weight (%)
Relative performance
Industry return versus ACWI · no future data shown
Is participation broad or concentrated?
Actual constituent counts at this date, not the legacy synthetic breadth proxy
This is size concentration, not contribution to the 12-month change. The attribution above measures the latter.
Evidence can disagree
Independent dimensions · no combined score or bullish/bearish verdict
Other evidence and availability
Valuation data: unavailable; shown as zero placeholder.
Attention data: unavailable; shown as zero placeholder.
Actual fund flows: unavailable. No ETF, mutual-fund or institutional flow feed is connected.
Volume / turnover: unavailable in this dataset.
Follow the contribution to individual companies
Sorted by absolute 12-month weight contribution, not investment merit
| Company | Sub-industry | Country | Universe weight | 12M contribution | 12M price return | Revisions |
|---|---|---|---|---|---|---|
| Johnson & Johnson → JNJ | Pharmaceuticals | United States | 1.309% | -0.809 pp | +9.2% | 0.0 |
| Pfizer → PFE | Pharmaceuticals | United States | 0.842% | -0.352 pp | +29.3% | 0.0 |
| Bristol Myers Squibb → BMY | Pharmaceuticals | United States | 0.290% | -0.294 pp | -12.9% | 0.0 |
| Merck & Co. → MRK | Pharmaceuticals | United States | 0.654% | -0.225 pp | +37.1% | 0.0 |
| Lilly (Eli) → LLY | Pharmaceuticals | United States | 0.418% | -0.094 pp | +49.3% | 0.0 |
| Zoetis → ZTS | Pharmaceuticals | United States | 0.150% | -0.063 pp | +22.9% | 0.0 |
Underlying monthly industry observations
| Month | Weight | 1M change | 3M change | 6M change | 12M change | Relative return · 12M |
|---|---|---|---|---|---|---|
| Nov 2018 | 3.663% | +0.123 pp | +0.363 pp | -1.749 pp | -1.837 pp | +29.3% |
| Oct 2018 | 3.539% | +0.173 pp | -2.235 pp | -2.061 pp | -1.961 pp | +22.7% |
| Sep 2018 | 3.366% | +0.067 pp | -2.136 pp | -2.235 pp | -2.134 pp | +14.8% |
| Aug 2018 | 3.300% | -2.475 pp | -2.112 pp | -2.242 pp | -2.201 pp | +11.7% |
| Jul 2018 | 5.774% | +0.272 pp | +0.174 pp | +0.274 pp | +0.274 pp | +8.2% |
| Jun 2018 | 5.502% | +0.091 pp | -0.099 pp | +0.002 pp | +0.002 pp | +2.0% |
| May 2018 | 5.411% | -0.189 pp | -0.130 pp | -0.089 pp | -0.089 pp | -0.5% |
| Apr 2018 | 5.600% | -0.001 pp | +0.100 pp | +0.100 pp | +0.100 pp | +1.2% |
| Mar 2018 | 5.601% | +0.060 pp | +0.101 pp | +0.101 pp | +0.101 pp | +1.6% |
| Feb 2018 | 5.542% | +0.042 pp | +0.042 pp | +0.042 pp | +0.042 pp | +1.2% |
| Jan 2018 | 5.500% | +0.000 pp | +0.000 pp | +0.000 pp | +0.000 pp | +0.0% |
How are these descriptive states defined?
Gaining / losing: 12-month weight change above +0.005pp / below −0.005pp. Direction and speed are separate dimensions, not mutually exclusive recommendations.
Accelerating / slowing: compare the most recent 3M change with the preceding 3M change. Accelerating means a positive change speeds up by >0.02pp. Slowing means the magnitude of movement declines by >0.02pp. A falling industry can also slow.
Reversing: the last two 3M changes have opposite signs, outside a ±0.005pp tolerance. Persistence counts consecutive same-direction monthly changes.
Broad / concentrated: company attribution, not a market-cap concentration shortcut. Concentrated means the three largest same-direction contributors account for ≥70% of gross same-direction changes; otherwise broad requires ≥60% of constituents moving with the industry. Other cases are mixed.
Weights use matched S&P 500 members’ market-cap estimates, based on SEC-reported shares available by each month-end and monthly closing prices. Companies without a matched price or share record are omitted, so the denominator is the matched sample rather than every index member. These are not official float-adjusted S&P weights. Flow is not measured.